Skip to search formSkip to main contentSkip to account menu

Patent ductus arteriosus - persisting type

Known as: DUCTUS ARTERIOSUS PATENT, PATENT DUCTUS ARTERIOSUS 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
ObjectiveTo evaluate the effectiveness of drugs used to constrict patent ductus arteriosus (PDA) in newborns < 28 weeks.MethodsWe… 
2014
2014
OBJECTIVE To study the concurrence of congenital heart disease and hypospadias and the relationship between the two diseases… 
Review
2009
Review
2009
SUMMARY Objective: To determine risk factors associated with the presence of complications with mechanical ventilatory support… 
Review
2009
Review
2009
OBJECTIVE To determine risk factors associated with the presence of complications with mechanical ventilatory support (MVS) in… 
2005
2005
AIM To assess the efficacy and safety of early treatment with ibuprofen (IBU) and indomethacin (INDO) of patent ductus arteriosus… 
Review
1997
Review
1997
OBJECTIVES To determine risk factors for Serratia marcescens infection or colonization, and to identify the source of the… 
1987
1987
The effect of patent ductus arteriosus (PDA) and its therapy on the pharmacokinetic disposition of gentamicin in very low birth… 
1975
1975